Digest Network Come funziona
Network
/
Società
Ca
Non verificato

Castle Biosciences Inc.

Di cosa scriviamo

BiotecnologiaOncologiaSaluteSanitàScienza

38 comunicati stampa

Guarda tutti i comunicati
07/03/2025
Eventi
Industria
Scienza
Farmaceutica
Oncologia
Salute
Biotecnologia
Sanità
New Data to be Presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting Further Strengthens Evidence Supporting the Clinical Value of Castle Biosciences' Dermatology Portfolio
Fonte
Castle Biosciences Inc.
Emittente
Business Wire
1.00
0
27/02/2025
Biotecnologia
Farmaceutica
Salute
Web e Social Network
Telefonia e Varie
Mercato azionario
Castle Biosciences Reports Fourth Quarter and Full-Year 2024 Results
Fonte
Castle Biosciences Inc.
Emittente
Business Wire
1.00
0
25/02/2025
Oncologia
Salute
Biotecnologia
Scienza
Farmaceutica
Web e Social Network
Telefonia e Varie
Eventi
Castle Biosciences to Participate in Upcoming Investor Conferences
Fonte
Castle Biosciences Inc.
Emittente
Business Wire
1.00
0
12/02/2025
Oncologia
Salute
Biotecnologia
Scienza
Farmaceutica
Fiere
Industria
Castle Biosciences to Share Data Reinforcing the Clinical Value of Its Dermatologic Portfolio of Gene Expression Profile Tests at the 22nd Annual Winter Clinical Dermatology Conference - Hawaii®
Fonte
Castle Biosciences Inc.
Emittente
Business Wire
1.00
0
06/02/2025
Attrezzature medico-sanitarie
Biotecnologia
Sanità
Salute
Scienza
Oncologia
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Castle Biosciences to Release Fourth Quarter and Full-Year 2024 Financial Results and Host Conference Call on Thursday, Feb. 27, 2025
Fonte
Castle Biosciences Inc.
Emittente
Business Wire
1.00
0
17/01/2025
Eventi
Industria
Scienza
Biotecnologia
Sanità
Medicina nucleare
Salute
Oncologia
Castle’s Poster on DecisionDx®-SCC Selected as a “Late Breakers” Top Five Finalist for the Akamai Award, Recognizing the Best Posters at Maui Derm Hawaii 2025
Fonte
Castle Biosciences Inc.
Emittente
Business Wire
1.00
0
12/01/2025
Mercato azionario
Biotecnologia
Sanità
Salute
Oncologia
Scienza
Attrezzature medico-sanitarie
Medicina - Varie
Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Results
Fonte
Castle Biosciences Inc.
Emittente
Business Wire
1.00
0
06/01/2025
Industria
Tecnica
Attrezzature medico-sanitarie
Biotecnologia
Salute
Oncologia
Castle Biosciences Announces New York State Department of Health Approval of Its TissueCypher® Barrett’s Esophagus Test
Fonte
Castle Biosciences Inc.
Emittente
Business Wire
1.00
0
23/12/2024
Industria
Biotecnologia
Farmaceutica
Sanità
Oncologia
Salute
Medicina - Varie
Castle Biosciences Highlights Progress for its Pipeline Atopic Dermatitis Gene Expression Profile Test
Fonte
Castle Biosciences Inc.
Emittente
Business Wire
1.00
0
19/12/2024
Mercato del lavoro
Finanza
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Castle Biosciences Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0